ATE132037T1 - Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln - Google Patents

Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln

Info

Publication number
ATE132037T1
ATE132037T1 AT93913148T AT93913148T ATE132037T1 AT E132037 T1 ATE132037 T1 AT E132037T1 AT 93913148 T AT93913148 T AT 93913148T AT 93913148 T AT93913148 T AT 93913148T AT E132037 T1 ATE132037 T1 AT E132037T1
Authority
AT
Austria
Prior art keywords
cyclodextrin
nanocapsules
production
application
optionally
Prior art date
Application number
AT93913148T
Other languages
English (en)
Inventor
Mohamed Skiba
Denis Wouessidjewe
Hatem Fessi
Jean-Philippe Devissaguet
Dominique Duchene
Francis Puisieux
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE132037T1 publication Critical patent/ATE132037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Colloid Chemistry (AREA)
AT93913148T 1992-06-16 1993-06-16 Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln ATE132037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929207285A FR2692167B1 (fr) 1992-06-16 1992-06-16 Préparation et application de nouveaux systèmes colloïdaux nanovésiculaires dispersibles à base de cyclodextrine, sous forme de nanocapsules.

Publications (1)

Publication Number Publication Date
ATE132037T1 true ATE132037T1 (de) 1996-01-15

Family

ID=9430799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913148T ATE132037T1 (de) 1992-06-16 1993-06-16 Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln

Country Status (7)

Country Link
EP (1) EP0646002B1 (de)
JP (1) JPH07507783A (de)
AT (1) ATE132037T1 (de)
DE (1) DE69301150T2 (de)
ES (1) ES2083291T3 (de)
FR (1) FR2692167B1 (de)
WO (1) WO1993025194A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
ES2078190B1 (es) * 1994-05-20 1996-08-01 Cusi Lab Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
FR2805761B1 (fr) 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
FR2808691B1 (fr) 2000-05-12 2005-06-24 Coletica Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine
ES2306684T3 (es) 2001-09-17 2008-11-16 Nanopart-C S.A. Nuevo sistema coloidal dispersable a base de calixareno en forma de nanoparticulas.
WO2004006959A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents
FR2903987B1 (fr) * 2006-07-21 2012-12-21 Centre Nat Rech Scient Nouveaux derives de cyclodextrines amphiphiles, leur utilisation dans les domaines pharmaceutiques,cosmetiques, alimentaires et leur application a la production de nouveaux nanosystemes
CN113089333B (zh) * 2021-03-31 2022-11-08 上海应用技术大学 一种基于氯丙醇-β-环糊精的双包埋囊泡及其制备方法
CN116327734A (zh) * 2023-04-11 2023-06-27 杭州师范大学 一种基于手性螺旋分子的纳米胶囊及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
FR2660193B1 (fr) * 1990-04-03 1994-11-04 Philippe Maincent Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.

Also Published As

Publication number Publication date
ES2083291T3 (es) 1996-04-01
DE69301150D1 (de) 1996-02-08
EP0646002B1 (de) 1995-12-27
WO1993025194A1 (fr) 1993-12-23
EP0646002A1 (de) 1995-04-05
FR2692167A1 (fr) 1993-12-17
FR2692167B1 (fr) 1994-09-16
DE69301150T2 (de) 1996-09-05
JPH07507783A (ja) 1995-08-31

Similar Documents

Publication Publication Date Title
ATE141161T1 (de) Herstellung und verwendung von, auf basis von cyclodextrin dispergierbaren kolloidal-systemen, in form von nanokugeln
MY100199A (en) Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
ATE74025T1 (de) Verfahren zur herstellung eines kolloidalen, dispersiblen systems von nanokapseln.
ATE202699T1 (de) Pharmazeutische von gelen auf mikroemulsionsbasis abgeleitete pharmazeutische präparate, verfahren für ihre herstellung und neue gele auf mikroemulsionsbasis
FR2608988B1 (fr) Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
FR2755856B1 (fr) Microcapsules de chitine ou de derives de chitine contenant une substance hydrophobe, notamment un filtre solaire et procede de preparation de telles microcapsules
ATE132037T1 (de) Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln
BR0008338A (pt) Composição e processo de lavagem de matérias queratìnicas e utilização da composição
KR920002759A (ko) 샴푸 조성물
KR960703316A (ko) 작물 보호 활성 화합물의 다상의 안정한 수성 가공 제제 및 이의 제조 방법(Aqueous, Multiphase, Stable Finished Formulation for Crop Protection Active Compounds and Its Preparation)
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DE69531179D1 (de) Nanoemulsion von dem Öl-in-Wasser Typ, gebrauchbar als ein ophthalmischen Vehikel und Verfahren zur seiner Herstellung
DE69620011D1 (de) Konditionierende shampoo-zusammensetzungen mit verbesserter stabilität
RU94045128A (ru) Эмульсия вода-в-масле, содержащая ретинол, способ ее получения и упаковка для эмульсии
BR9801063A (pt) Processo para produzir um sistema líquido, e, uso do sistema líquido
KR920002758A (ko) 샴푸 시스템
DE3770830D1 (de) Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
NL194612B (nl) Aromatische, alkenisch onverzadigde retino´den, alsmede dergelijke verbindingen bevattende farmaceutische en cosmetische preparaten.
KR890014079A (ko) 모발용 화장품 조성물
CA2243602A1 (fr) Emulsion eau-dans-huile comprenant de la silice pyrogenee et un alkylether de polysaccharide
KR870000931A (ko) 피부탄력 섬유증(纖維症) 예방제의 제법
DE59600039D1 (de) Verfahren zur Herstellung von hochaktiven, stabilen Metallocen-Katalysatorsystemen und gemäss diesem Verfahren hergestellte Formulierungen
KR890009375A (ko) 리포좀을 함유한 화장료의 제조방법
MX172446B (es) Composiciones blanqueadoras liquidas, acuosas, concentradas
TH19058A (th) องค์ประกอบของเครื่องสำอางและกระบวนการสำหรับการเตรียม (cosmetic composition and process for making it)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties